← Leaderboards
Joel D Taurog
University Of Texas Sw Med Ctr/Dallas
$5,546,607
Attributed
$5,546,607
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $603K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,546,607 · 5
By mechanism
R01$4,169,783 · 2
T32$959,784 · 1
R21$392,040 · 1
R13$25,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Robert Joseph Gatchel$9,390,119
- Peter E Lipsky$1,069,221
Others in their field
Top investigators on “Mhc Class I Antigen”
- Kent J. Weinhold · Duke University$40,222,851
- Alessandro Sette · La Jolla Institute For Immunology$38,991,506
- David I Watkins · George Washington University$29,948,799
- Hidde L Ploegh · Boston Children'S Hospital$28,911,681
- Stephen S. Rich · University Of Alabama At Birmingham$26,347,668
- John Altman · Emory University$22,835,835
Research focus
Mhc Class I AntigenGenetically Modified AnimalsAntigen PresentationRheumatismGenesAnkylosing SpondylitisMolecularHla-B27 AntigenPathogenesisMass SpectrometryPathway InteractionsTransgenesInflammatoryPredispositionProductionDisease /Disorder ModelAllelesCellsCytotoxic T LymphocytePhenotypeChronicInflammationRattusTransgenic Organisms
Grant awards (20)
Genome-targeted IL-23 receptor reporter rats for studying HLA-B27-dependent spondyloarthritis$178,200
R21 · FY2020 · AR · contact PI
Genome-targeted IL-23 receptor reporter rats for studying HLA-B27-dependent spondyloarthritis$213,840
R21 · FY2019 · AR · contact PI
HLA-B27 and Experimental Spondyloarthropathy$424,041
R01 · FY2009 · AR · contact PI
Workshop on the Role of HLA-B27 in Spondyloarthritis$25,000
R13 · FY2009 · AR · contact PI
HLA-B27 and Experimental Spondyloarthropathy$413,090
R01 · FY2008 · AR · contact PI
HLA-B27 and Experimental Spondyloarthropathy$410,645
R01 · FY2007 · AR · contact PI
HLA-B27 and Experimental Spondyloarthropathy$412,012
R01 · FY2006 · AR · contact PI
HLA-B27 and Experimental Spondyloarthropathy$411,058
R01 · FY2005 · AR
Basic and Clinical Rheumatology$191,980
T32 · FY2005 · AR
Basic and Clinical Rheumatology$217,612
T32 · FY2004 · AR
ROLE OF HLA-B27 IN EXPERIMENTAL SPONDYLOARTHROPATHY$353,583
R01 · FY2003 · AR
Basic and Clinical Rheumatology$133,359
T32 · FY2003 · AR
ROLE OF HLA-B27 IN EXPERIMENTAL SPONDYLOARTHROPATHY$345,649
R01 · FY2002 · AR
Role of T Cells in Experimental Spondyloarthropathy$251,077
R01 · FY2002 · AI
Basic and Clinical Rheumatology$224,525
T32 · FY2002 · AR
EXPERIMENTAL SPONDYLOARTHROPATHY$337,941
R01 · FY2001 · AR
Role of T Cells in Experimental Spondyloarthropathy$243,766
R01 · FY2001 · AI
Basic and Clinical Rheumatology$192,308
T32 · FY2001 · AR
EXPERIMENTAL SPONDYLOARTHROPATHY$330,257
R01 · FY2000 · AR
Role of T Cells in Experimental Spondyloarthropathy$236,664
R01 · FY2000 · AI